AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Introduction
This chapter explores the recent success and valuation of Novo Nordisk, discussing their strong profits from anti-obesity and diabetes drugs and the impact of their corporate structure as a non-profit foundation on research advances.